Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2016

01-10-2016 | Review

Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence

Authors: Tong Li, Claudia Mello-Thoms, Patrick C. Brennan

Published in: Breast Cancer Research and Treatment | Issue 3/2016

Login to get access

Abstract

Breast cancer is the most common neoplasm diagnosed amongst women worldwide and is the leading cause of female cancer death. However, breast cancer in China is not comprehensively understood compared with Westernised countries, although the 5-year prevalence statistics indicate that approximately 11 % of worldwide breast cancer occurs in China and that the incidence has increased rapidly in recent decades. This paper reviews the descriptive epidemiology of Chinese breast cancer in terms of incidence, mortality, survival and prevalence, and explores relevant factors such as age of manifestation and geographic locations. The statistics are compared with data from the Westernised world with particular emphasis on the United States and Australia. Potential causal agents responsible for differences in breast cancer epidemiology between Chinese and other populations are also explored. The need to minimise variability and discrepancies in methods of data acquisition, analysis and presentation is highlighted.
Appendix
Available only for authorised users
Footnotes
1
The population-based data regarding specific cancer from China National Cancer Centre is available since 2003.
 
2
Average ASR has been standardised to world Segi’s population.
 
Literature
1.
2.
3.
4.
Anderson BO, Yip C-H, Ramsey SD, Bengoa R, Braun S, Fitch M, Groot M, Sancho-Garnier H, Tsu VD, Global Summit Health Care Systems and Public Policy Panel (2006) Breast cancer in limited-resource countries: health care systems and public policy. Breast J 12(s1):S54. doi:10.​1111/​j.​1075-122X.​2006.​00203.​x PubMedCrossRef
5.
6.
7.
8.
Anderson BO, Yip C-H, Smith RA, Shyyan R, Sener SF, Eniu A, Carlson RW, Azavedo E, Harford J (2008) Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer 113(8 Suppl):2221–2243. doi:10.​1002/​cncr.​23844 PubMedCrossRef
9.
Hortobagyi GN, Namer M, O’shaughnessy JA, Zhou Shen Z, Albain KS, De La Garza Salazar J, Pritchard K, Amadori D, Haidinger R, Hudis CA, Khaled H, Liu M-C, Martin M, Investigators A (2005) The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 6(5):391–401. doi:10.​3816/​CBC.​2005.​n.​043 PubMedCrossRef
10.
11.
12.
Li J, Zhang B-N, Fan J-H, Pang Y, Zhang P, Wang S-L, Zheng S, Zhang B, Yang H-J, Xie X-M, Tang Z-H, Li H, Li J-Y, He J-J, Qiao Y-L (2011) A Nation-wide multicenter 10-year (1999–2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer 11(1):1–11. doi:10.​1186/​1471-2407-11-364 CrossRef
13.
14.
Gondos A, Arndt V, Holleczek B, Stegmaier C, Ziegler H, Brenner H (2007) Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Int J Cancer 121(2):395–400. doi:10.​1002/​ijc.​22683 PubMedCrossRef
15.
Yang G, Naghavi M, Vos T, Wang H, Lopez AD, Murray CJL, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, Wan X, Yu S, Jiang Y (2013) Rapid health transition in China, 1990–2010: findings from the global burden of disease study 2010. Lancet 381(9882):1987. doi:10.​1016/​S0140-6736(13)61097-1 PubMedCrossRef
16.
17.
18.
19.
20.
21.
National Office for Cancer Prevention and Control & National Central Cancer Registry, Disease Prevention and Control Bureau Ministry of Health (2009) 2008 Chinese cancer registry annual report: cancer incidence and mortality in Chinese cancer registration areas in 2005. Military Medical Science Press, Beijing
22.
National Office for Cancer Prevention and Control, National Cantreal Cancer Registry, Disease Prevention and Control Bureau MOH (2008) China cancer registration annual report 2004. Peking Union Medical College Press, Beijing
23.
Huang Z-Z, Chen W-Q, Chun-Xiao W, Rong-Shou Z, Jian-Guo C, Nian-Nian Y, Ning W, Si-Wei Z, Ying X (2012) Incidence and mortality of female breast cancer in China—a report from 32 Chinese cancer registries, 2003–2007. TUMOR 32(6):435–439. doi:10.​3781/​j.​issn.​1000-7431.​2012.​06.​007
24.
25.
Australian Institute of Health and Welfare (2016) Australian cancer incidence and mortality books: breast cancer. Australian Institute of Health and Welfare, Canberra
26.
U.S. Cancer Statistics Working Group (2015) United States cancer statistics: 1999–2012 incidence and mortality web-based report. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta
27.
Australian Institute of Health and Welfare, Cancer Australia (2012) Breast cancer in Australia: an overview. Cancer series no. 71. Cat. no. CAN 67. Australian Institute of Health and Welfare, Canberra
28.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin D, Forman D, Bray F (eds) (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon
29.
30.
31.
32.
33.
34.
Wang N, Yuan Y-N, Rong-Shou Z, Sun X, Wang Q-S, He Y-T, Chen W-Q (2013) An analysis on difference of cancer incidence between urban and rural areas in China 2009. China Cancer 22(3):168–173
35.
36.
Li N, Zheng R-S, Zhang S-W, Zou X-N, Zeng H-M, Dai Z, Wan-Qing C (2012) Analysis and prediction of breast cancer incidence trend in China. Chinese Journal of Preventive Medicine 46(8):703–707PubMed
37.
Fan L, Zheng Y, Yu K-D, Liu G-Y, Wu J, Lu J-S, Shen K-W, Shen Z-Z, Shao Z-M (2009) Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat 117(2):409–416. doi:10.​1007/​s10549-008-0303-z PubMedCrossRef
38.
Wang Q, Li J, Zheng S, Li J-Y, Pang Y, Huang R, Zhang B-N, Zhang B, Yang H-J, Xie X-M, Tang Z-H, Li H, He J-J, Fan J-H, Qiao Y-L (2012) Breast cancer stage at diagnosis and area-based socioeconomic status: a multicenter 10-year retrospective clinical epidemiological study in China. BMC Cancer 12(1):122PubMedPubMedCentralCrossRef
39.
40.
Hui L, Zhong-Hua T, Hui L, Jian-Jun H, Qiong W, Yuan H, You-Lin Q, Yi P, Jia-Yuan L, Jin-Hu F, Jing L, Rong H, Bao-Ning Z, Bin Z, Hong-Jian Y, Xiao-Ming X (2014) Risk factors for breast cancer among Chinese women: a 10-year nationwide multicenter cross-sectional study. J Epidemiol 24(1):67CrossRef
41.
National Office for Cancer Prevention and Control & National Central Cancer Registry, Disease Prevention and Control Bureau Ministry of Health (2010) 2009 Chinese cancer registry annual report: cancer incidence and mortality in Chinese cancer registration areas in 2006. Military Medical Science Press, Beijing
42.
National Office for Cancer Prevention and Control & National Central Cancer Registry, Disease Prevention and Control Bureau Ministry of Health (2011) 2010 Chinese cancer registry annual report: cancer incidence and mortality in Chinese cancer registration areas in 2007. Military Medical Science Press, Beijing
43.
Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekruse S, Kosary C, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis D, Chen H, Feuer E, Cronin KE (2013) SEER cancer statistics review, 1975–2011. National Cancer Institute, Bethesda, Rockville
44.
Australian Bureau of Statistics (2013) ABS deaths, Australia (cat. no. 3302.0). Australian Bureau of Statistics, Canberra
45.
46.
National Center for Health Statistics (2014) Health, United States, 2013: with special feature on prescription drugs. National Center for Health Statistics, Hyattsville
47.
48.
49.
50.
Minami Y, Tsubono Y, Nishino Y, Ohuchi N, Shibuya D, Hisamichi S (2004) The increase of female breast cancer incidence in Japan: emergence of birth cohort effect. Int J Cancer 108(6):901–906. doi:10.​1002/​ijc.​11661 PubMedCrossRef
51.
Chen W-Q, Zheng R-S, Wang N, He Y-T, Wang Q-S, Sun X-B, He J (2013) Comparing study of cancer incidence between east and middle-west region in China. China Cancer 22(3):1
52.
53.
Chia KS, Reilly M, Tan CS, Lee J, Pawitan Y, Adami HO, Hall P, Mow B (2005) Profound changes in breast cancer incidence may reflect changes into a westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer 113(2):302–306. doi:10.​1002/​ijc.​20561 PubMedCrossRef
54.
55.
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin. doi:10.​3322/​caac.​21338
56.
57.
Goss PE, Sheikine Y, Chen Z, Qiao Y-L, Shao Z, Wu Y-L, Fan D, Chow LWC, Wang J, Zhang Q, Yu S, Strasser-Weippl K, Shen G, He J, Purushotham A, Sullivan R, Badwe R, Banavali SD, Nair R, Kumar L, Parikh P, Subramanian S, Lee-Bychkovsky BL, Chaturvedi P, Iyer S, Shastri SS, Digumarti R, Soto-Perez-De-Celis E, Adilbay D, Semiglazov V, Orlov S, Kaidarova D, Tsimafeyeu I, Fan L, Tatishchev S, Danishevskiy KD, Hurlbert M, Vail C, St Louis J, Chan A, Li J, Chavarri-Guerra Y, Liedke PER, Pramesh CS, Badovinac-Crnjevic T (2014) Challenges to effective cancer control in China, India, and Russia. Lancet Oncol 15(5):489. doi:10.​1016/​S1470-2045(14)70029-4 PubMedCrossRef
58.
59.
Zhang S-W, Chen W-Q, Kong L-Z, Zhao P (2007) An annual report: cancer incidence in 35 cancer registries in China, 2003. China Cancer 16(7):494–507
60.
61.
Yang L, Li L-D, Chen Y-D, Parkin DM (2006) Time trends, estimates and projects for breast cancer incidence and mortality in China. Chinese J Oncol 28(6):438–440
62.
Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002) Cancer incidence in five continents, vol VIII. International Agency for Research on Cancer, Lyon
63.
64.
Leung G, Thach T, Lam T, Hedley A, Foo W, Fielding R, Yip P, Lau E, Wong C (2002) Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis. British J Cancer 87(9):982–988CrossRef
65.
Wong IOL, Cowling BJ, Schooling CM, Leung GM (2007) Age-period-cohort projections of breast cancer incidence in a rapidly transitioning Chinese population. Int J Cancer 121(7):1556–1563. doi:10.​1002/​ijc.​22731 PubMedCrossRef
66.
67.
68.
69.
Yu H, Harris RE, Gao YT, Gao R, Wynder EL (1991) Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. Int J Epidemiol 20(1):76–81. doi:10.​1093/​ije/​20.​1.​76 PubMedCrossRef
70.
Chen W-Q, Zheng R-S, Zeng H-M, Zhang S-W, Zhao P, He J (2012) Trend analysis and projection of cancer incidence in China between 1989 and 2008. Chinese J Oncol 34(7):517–524
71.
Yang L, Parkin DM, Ferlay J, Li LA, Chen YD (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomark Prev 14(1):243–250
72.
73.
Youlden DR, Cramb SM, NaM Dunn, Muller JM, Pyke CM, Baade PD (2012) The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 36(3):237PubMedCrossRef
74.
75.
Population Census Office under States Council Department of Population and Employment Statistics, China National Bureau of Statistics (2011) Major figures on 2010 population census of China. China Satistics Press, Beijing
76.
Australian Institute of Health and Welfare (2013) Breast Screen Australia monitoring report 2010–2011. Cancer series no. 77. Cat. no. CAN 74. Australian Institute of Health and Welfare, Canberra
77.
Stewart BW, Wild CP (eds) (2014) World cancer report 2014. WHO Press, World Health Organization, Geneva
78.
Berry DA, Feuer EJ, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JDF, Cancer I, Surveillance Modeling Network C, Collaborators C (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. The New England J Med 353(17):1784–1792. doi:10.​1056/​NEJMoa050518 CrossRef
79.
80.
81.
Youlden DR, Cramb SM, Yip CH, Baade PD (2014) Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol & Med 11(2):101
82.
National Office for Cancer Prevention and Control, National Cantreal Cancer Registry, Disease Prevention and Control Bureal Ministry of Health (2010) National report of cancer mortality: report of the third national retrospective sample survey of mortality, China. People’s Medical Publishing House Co., LTD, Beijing
83.
84.
85.
86.
Shu XO, Zheng W, Jin F, Dai Q, Shi JR, Potter JD, Brinton LA, Hebert JR, Ruan Z, Gao YT (2001) Association of body size and fat distribution with risk of breast cancer among Chinese women. Int J Cancer 94(3):449–455. doi:10.​1002/​ijc.​1487 PubMedCrossRef
87.
88.
89.
Sankaranarayanan R, Yeole BB, Shin HR, Shanta V, Woo ZH, Martin N, Sumitsawan Y, Sriplung H, Barboza AO, Eser S, Nene BM, Swaminathan R, Suwanrungruang K, Jayalekshmi P, Dikshit R, Wabinga H, Esteban DB, Laudico A, Bhurgri Y, Bah E, Al-Hamdan N, Brenner H, Chen K, Chen JG, Chia KS, Law SCK, Ahn Y-O, Xiang YB (2010) Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 11(2):165–173. doi:10.​1016/​S1470-2045(09)70335-3 PubMedCrossRef
90.
Chen JG, Li WG, Shen ZC, Yao HY, Zhang BC, Zhu YR (1998) Population-based cancer survival in Qidong, People’s Republic of China. In: Sankaranarayanan R, Black RJ, Parkin DM (eds) Cancer survical in developing countries, vol 145. International Agency for Research on Cancer, Lyon, pp 27–35
91.
Jin F, Xiang YB, Gao YT (1998) Cancer survival in Shanghai, People’s Republic of China. In: Sankaranarayanan R, Black RJ, Parkin DM (eds) Cancer survial in developing countries. International Agency for Research on Cancer, Lyon, pp 37–50
92.
Xuiang YB, Jin F, Gao YT (2011) Cancer survival in Shanghai, China, 1992–1995. In: Sankaranarayanan R, Swaminathan R, Lucas E (eds) Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan), vol 162. International Agency for Research on Cancer, Lyon, pp 55–68
93.
Chen JG, Zhu J, Zhang YH, Lu JH (2011) Cancer survival in Qidong, China, 1992−2000. In: Sankaranarayanan R, Swaminathan R, Lucas E (eds) Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan), vol 162. International Agency for Reearch on Cancer, Lyon, pp 43–53
94.
Xishan H, Chen K, Min H, Shufen D, Jifang W (2011) Cancer survival in Tianjin, China, 1991–1999. In: Sankaranarayanan R, Swaminathan R, Lucas E (eds) Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan), vol 162. International Agency for Research on Cancer, Lyon, pp 69–84
95.
Black RJ, Parkin DM, Sankaranarayanan R, International Agency for Research On C (1998) Cancer survival in developing countries, vol no. 145. International Agency for Research on Cancer, Lyon
96.
Coleman MP, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, E Silva GA, Francisci S, Santaquilani M, Quaresma M, Verdecchia A, Storm HH, Young JL, Berrino F, Lutz J-M, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Group CW (2008) Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 9(8):730–756. doi:10.​1016/​S1470-2045(08)70179-7 PubMedCrossRef
97.
Brenner H, Sant M, Francisci S, De Angelis R, Marcos-Gragera R, Verdecchia A, Gatta G, Allemani C, Ciccolallo L, Coleman M, Group EW (2009) Long-term survival expectations of cancer patients in Europe in 2000–2002. European J Cancer (Oxford, England: 1990) 45(6):1028–1041. doi:10.​1016/​j.​ejca.​2008.​11.​005 CrossRef
98.
Sankaranarayanan R, Swaminathan R, Lucas E (2011) Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan). vol IARC Scientific Publications volume 162. International Agency for Research on Cancer, Lyon
99.
100.
Coleman MP, Hatcher J, Mcgahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Forman D, Morris EJ, Middleton R, Steward J, Richards MA, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Group IMW (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377(9760):127–138. doi:10.​1016/​S0140-6736(10)62231-3 PubMedPubMedCentralCrossRef
101.
102.
Qi-Jun W, Zhu W-X, Xing X-M (2006) Analysis of the incidence and survival of female breast cancer in Beijing during the last 20 years. Chinese J Oncol 28(3):208–210
103.
Tan BKT, Lim GH, Czene K, Hall P, Chia KS (2009) Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm. Breast cancer res: BCR 11(1):R4–R4. doi:10.​1186/​bcr2219 PubMedPubMedCentralCrossRef
104.
105.
106.
Cronin KA, Feuer EJ, Clarke LD, Plevritis SK (2006) Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis. J Natl Cancer Inst Monogr 36:112PubMedCrossRef
107.
Gondos A, Bray F, Hakulinen T, Brenner H, The ESWG, Group ESW (2009) Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 20(3):564–573. doi:10.​1093/​annonc/​mdn639 CrossRef
108.
109.
Goldhirsch A, Glick JH, Gelber RD, Coates AS, Hans-Jörg S (2001) Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Clin Oncol 19(18):3817–3827PubMed
110.
111.
Sant M, Bell J, Youngson J, Berrino F, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P, Martinez C, Group EW, The EWG (2003) Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106(3):416–422. doi:10.​1002/​ijc.​11226 PubMedCrossRef
112.
Youlden DR, Cramb SM, Baade PD (2009) Current status of female breast cancer in Queensland: 1982 to 2006. Viertel Centre for Research in Cancer Control, Cancer Council Queensland
113.
Ries LaG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J (2007) SEER survival monograph: cancer survival among adults: U.S. SEER program, 1988-2001, patient and tumor characteristics. National Cancer Institute, SEER Program, Bethesda, Rockville
114.
Australian Institute of Health and Welfare, National Breast and Ovarian Cancer Centre (2009) Breast cancer in Australia: an overview, 2009. Cancer series no. 50. Cat. no. CAN 46. Australian Institute of Health and Welfare, Canberra
115.
Australian Institute of Health and Welfare, National Breast Cancer Centre (2006) Breast cancer in Australia: an overview, 2006. Cancer series no. 34. cat. no. CAN 29. Australian Institute of Health and Welfare, Canberra
116.
117.
Australian Institute of Health and Welfare, National Breast Cancer Centre (2007) Breast cancer survival by size and nodal status in Australia. Cancer Series no. 39. Cat. no. CAN 34. Australian Institute of Health and Welfare, Canberra
118.
119.
Yu Z-G, Jia C-X, Liu L-Y, Geng C-Z, Tang J-H, Zhang J, Zhang Q, Li Y-Y, Ma Z-B (2012) The prevalence and correlates of breast cancer among women in Eastern China. PLoS One 7(6):e37784PubMedPubMedCentralCrossRef
Metadata
Title
Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence
Authors
Tong Li
Claudia Mello-Thoms
Patrick C. Brennan
Publication date
01-10-2016
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2016
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-016-3947-0

Other articles of this Issue 3/2016

Breast Cancer Research and Treatment 3/2016 Go to the issue

Preclinical Study

Exercise regulates breast cancer cell viability: systemic training adaptations versus acute exercise responses

Epidemiology

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women

Clinical trial

Genomic profiling of breast cancer in African-American women using MammaPrint

Clinical trial

BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy

Epidemiology

Understanding racial differences in health-related quality of life in a population-based cohort of breast cancer survivors

Brief Report

Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2): positive advanced breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits